Axon HR chief granted 6,818 performance stock units

AXON ENTERPRISE, INC. reported that officer Elizabeth Reid Coughlin, Chief Human Officer, acquired 6,818 shares of common stock in the form of performance-based restricted stock units (XSUs).

Rhea-AI Filing Summary

AXON ENTERPRISE, INC. reported that officer Elizabeth Reid Coughlin, Chief Human Officer, acquired 6,818 shares of common stock in the form of performance-based restricted stock units (XSUs). These units relate to a grant made on December 22, 2023, for which the fourth tranche’s performance conditions were certified as achieved on August 16, 2026. The tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the shares will be subject to a minimum holding period extending to the earlier of December 31, 2030 or the vesting of a subsequent tranche. Following this acquisition, Coughlin holds 40,841.833 shares of Axon common stock directly.

Insider Trade Summary

Grant/Award: 6,818 shares

Grant/Award 1 txn

Insider Coughlin Elizabeth Reid

Role Chief Human Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	6,818	$0.00	$0.00

Holdings After Transaction: Common Stock — 40,841.833 shares (Direct)

Footnotes (1)

1. F1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

Key Figures

XSUs acquired: 6,818 shares Shares held after transaction: 40,841.833 shares Transaction price per share: $0.0000 per share +2 more

5 metrics

XSUs acquired 6,818 shares Performance-based restricted stock units in fourth tranche certified on August 16, 2026

Shares held after transaction 40,841.833 shares Direct ownership following the reported Form 4 transaction

Transaction price per share $0.0000 per share Award of XSUs reported with a zero-dollar per-share transaction price

Tranche vesting date December 1, 2026 Scheduled vesting date for the fourth tranche of XSUs, subject to continued employment

Minimum holding period end December 31, 2030 Latest date for minimum holding period on delivered shares, unless a later tranche vests earlier

Key Terms

performance-based restricted stock units, 2024 eXponential Stock Plan, Compensation Committee, minimum holding period

4 terms

performance-based restricted stock units financial

"The transaction consists of performance-based restricted stock units (collectively, "XSUs")"

Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.

2024 eXponential Stock Plan financial

"granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan"

Compensation Committee financial

"certified by the issuer's Compensation Committee of the Board of Directors"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

minimum holding period financial

"subject to a minimum holding period until the earlier of (i) December 31, 2030"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AXON (AXON) disclose about Elizabeth Reid Coughlin’s recent equity award?

AXON disclosed that Elizabeth Reid Coughlin acquired 6,818 performance-based restricted stock units tied to common stock. These units are part of a 2023 grant whose fourth tranche performance conditions were certified as met on August 16, 2026.

When will the new XSUs for AXON’s Elizabeth Reid Coughlin vest?

The fourth tranche of XSUs is scheduled to vest on December 1, 2026, subject to Coughlin’s continued employment. Only after vesting will the underlying shares be delivered, with an additional minimum holding period imposed afterward.

What holding restrictions apply to the new AXON XSUs for Elizabeth Reid Coughlin?

After vesting, the shares from the tranche are subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a later tranche, excluding any shares withheld or sold to cover applicable taxes.

How many AXON shares does Elizabeth Reid Coughlin hold after this Form 4 transaction?

Following this transaction, Elizabeth Reid Coughlin directly holds 40,841.833 shares of AXON common stock. This figure includes the impact of the certified performance-based tranche reported in the Form 4 filing.

What plan governs the AXON XSUs reported for Elizabeth Reid Coughlin?

The XSUs are governed by the Axon Enterprise, Inc. 2024 eXponential Stock Plan. The certified tranche represents the fourth portion of a performance-based award granted under this plan on December 22, 2023.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 05:18 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coughlin Elizabeth Reid

(Last) (First) (Middle)

17800 N 85TH ST

(Street)

SCOTTSDALE ARIZONA 85255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/16/2026		A(1)		6,818	A	$0	40,841.833	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

Remarks:

	/s/ Elizabeth Reid Coughlin, by Isaiah Fields, Attorney-in-Fact	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)